Notable Analyst Rating Changes 12/31: (FB) (PMFG) (BMY) Upgraded; (FOE) Downgraded
Get Alerts FB Hot Sheet
Join SI Premium – FREE
UPGRADES
BMO Capital upgrades Facebook (Nasdaq: FB) from Underperform to Outperform, more than doubling its price target from $15 to $32. Click Here for more color.
Needham & Company hoists PMFG, Inc. (Nasdaq: PMFG) up from Hold to Buy with a price target of $11. Click Here for more color.
Atlantic Equities lifts Bristol-Myers Squibb Co. (NYSE: BMY) from Underweight to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Monness, Crespi, Hardt downgrades Ferro Corp. (NYSE: FOE) from Buy to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
WhiteHorse Finance (Nasdaq: WHF) started by four firms today:
Piper Jaffray initiates Galena Biopharma (Nasdaq: GALE) with an Overweight and $2.50 price target.
Goldman Sachs assumes Alon USA Energy (NYSE: ALJ) at Buy and $21 price target. Click Here for more color.
Barrington Research begins TranS1 Inc (Nasdaq: TSON) with a Outperform and $4 target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
BMO Capital upgrades Facebook (Nasdaq: FB) from Underperform to Outperform, more than doubling its price target from $15 to $32. Click Here for more color.
Needham & Company hoists PMFG, Inc. (Nasdaq: PMFG) up from Hold to Buy with a price target of $11. Click Here for more color.
Atlantic Equities lifts Bristol-Myers Squibb Co. (NYSE: BMY) from Underweight to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Monness, Crespi, Hardt downgrades Ferro Corp. (NYSE: FOE) from Buy to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
WhiteHorse Finance (Nasdaq: WHF) started by four firms today:
- Stifel Nicolaus at Buy and $16 price target;
- Citi with a Buy and price target of $16;
- JPMorgan at Overweight; and
- Baird with an Outperform and $17 price target.
Piper Jaffray initiates Galena Biopharma (Nasdaq: GALE) with an Overweight and $2.50 price target.
Goldman Sachs assumes Alon USA Energy (NYSE: ALJ) at Buy and $21 price target. Click Here for more color.
Barrington Research begins TranS1 Inc (Nasdaq: TSON) with a Outperform and $4 target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Needham Reiterates Buy Rating on Amazon.com (AMZN), Raises Estimates
- Texas Instruments (TXN) jumps on first above-consensus guide in seven years
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Piper Jaffray, Stifel, JPMorgan, Citi, Robert W Baird, Needham & Company, BMO Capital, Notable Analyst Rating ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!